112.49
Genedx Holdings Corp stock is traded at $112.49, with a volume of 1.38M.
It is up +1.33% in the last 24 hours and up +22.01% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$111.01
Open:
$111.39
24h Volume:
1.38M
Relative Volume:
1.40
Market Cap:
$2.60B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-36.17
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+23.56%
1M Performance:
+22.01%
6M Performance:
+100.66%
1Y Performance:
+915.25%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
WGS
Genedx Holdings Corp
|
112.49 | 2.60B | 267.23M | -83.50M | -59.99M | -3.11 |
![]()
TMO
Thermo Fisher Scientific Inc
|
421.34 | 159.25B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
195.91 | 132.37B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
433.99 | 32.95B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
106.87 | 28.58B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
150.13 | 24.90B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jul-10-24 | Initiated | Craig Hallum | Buy |
Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx: Strengthening Leadership In Genomic Diagnostics (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? - MSN
(WGS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand - Insider Monkey
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition - Yahoo
GeneDx to acquire AI genomics firm Fabric Genomics By Investing.com - Investing.com South Africa
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million - Benzinga
GeneDx to Acquire Fabric Genomics for Up to $51 Million - marketscreener.com
GeneDx to acquire Fabric Genomics in a deal worth up to $51M - MSN
GeneDx Holdings Acquires Fabric Genomics for $33 Million - TipRanks
GeneDx to acquire AI genomics firm Fabric Genomics - Investing.com Australia
GeneDx stock in focus on Fabric Genomics buyout (WGS:NASDAQ) - Seeking Alpha
Genedx To Acquire Fabric Genomics - marketscreener.com
Major AI Genomics Deal: GeneDx Acquires Fabric to Transform Global Genetic Testing - Stock Titan
GeneDx (WGS) to Acquire Fabric Genomics in $51M Deal - GuruFocus
Is GeneDx Holdings Corp. (NASDAQ:WGS) Trading At A 31% Discount? - simplywall.st
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock By Investing.com - Investing.com India
GeneDx CFO Kevin Feeley sells $1.43 million in stock By Investing.com - Investing.com South Africa
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock - Investing.com Australia
GeneDx CFO Kevin Feeley sells $1.43 million in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares - TradingView
GeneDx Q1 2025 Earnings Coming: Key Financial Results Set for April 30 - Stock Titan
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025 - Yahoo Finance
Why GeneDx Holdings Shares Are Under Pressure - TipRanks
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Yahoo Finance
Prudential Financial Inc. Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Achieves 40% Diagnostic Success Rate in Rare Immune Disease Testing - Stock Titan
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
GeneDx CEO Stueland sells $4.45 million in stock By Investing.com - Investing.com UK
Victory Capital Management Inc. Acquires Shares of 2,720 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
7 Up-and-Coming Stocks to Buy in 2025 - US News Money
How To Trade (WGS) - news.stocktradersdaily.com
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - simplywall.st
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $96,416.32 in Stock - MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - Stock Titan
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):